ZTS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zoetis Inc (ZTS) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks clear positive momentum, is in a bearish technical trend, and has mixed analyst sentiment. While financial performance shows modest growth, the company's innovation pipeline is in a temporary slowdown, and there are no recent catalysts to drive significant upside. Holding or waiting for a better entry point is recommended.
The stock is in a bearish trend with moving averages showing SMA_200 > SMA_20 > SMA_5. The MACD histogram is negative (-0.218) and contracting, while RSI_6 is neutral at 42.428. The stock is trading below its pivot level of 117.572, with key support at 114.05 and resistance at 121.094.
Hedge funds have increased buying activity by 228.26% over the last quarter. Financial performance shows modest YoY growth in revenue (3.02%), net income (3.79%), and EPS (6.98%).
Analysts have downgraded the stock due to concerns about a lack of organic growth and an 'innovation air pocket' that could last 1-2 years. Technical indicators are bearish, and the stock has a 50% chance to decline further in the short term (-0.26% next day, -0.79% next week, -1.27% next month).
In Q4 2025, Zoetis reported revenue of $2.387 billion (+3.02% YoY), net income of $603 million (+3.79% YoY), EPS of $1.38 (+6.98% YoY), and a gross margin of 68.96% (+1.38% YoY). While these figures show modest growth, they do not indicate significant acceleration.
Recent analyst sentiment is mixed to negative. Nephron Research downgraded the stock to Hold with a $131 price target, citing a lack of organic growth. Piper Sandler also downgraded the stock to Neutral, citing concerns about the company's innovation pipeline and consumer spending environment. BofA raised its price target slightly to $140 but maintained a Neutral rating.
